Name | (2S)-2-[(2,6-difluorobenzoyl)amino]-3-[4-[4-(ethoxymethyl)-2,6-dimethoxyphenyl]phenyl]propanoic acid |
---|---|
Synonyms |
Firategrast (USAN)
Firategrast UNII-OJY3SK9H5F |
Description | Firategrast is an orally bioavailable α4β1/α4β7 integrin antagonist. |
---|---|
Related Catalog | |
Target |
α4β1/α4β7[1] |
In Vitro | Firategrast is an orally bioavailable α4β1/α4β7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS)[1]. |
References |
Molecular Formula | C27H27F2NO6 |
---|---|
Molecular Weight | 499.50300 |
Exact Mass | 499.18100 |
PSA | 97.58000 |
LogP | 5.18600 |
Storage condition | 2-8℃ |